Patients who received subconjunctival triamcinolone had signficantly decreased macular thickness than those who did not.
No patient who received subconjunctival triamcinolone acetonide developed cystoid macular oedema.
Intravitreal bevacizumab had no significant effect on macular thickness.
Source Archive